(Reuters) -SoftBank Group-backed Tempus AI set the pricing of its U.S. preliminary public providing at $37 per share on Thursday, aiming to lift $410.7 million.
The genetics-testing firm priced its IPO on the greater finish of is focused vary of $35 to $37, valuing the agency at about $6.10 billion, primarily based on the excellent shares listed in its submitting with the U.S. Securities and Change Fee.
Tempus AI’s shares are anticipated to start out buying and selling on Nasdaq International Choose Market on Friday.
The itemizing of the corporate, which is led by e-commerce market Groupon co-founder Eric Lefkofsky and is but to be worthwhile, will check investor urge for food.
Tempus sells genomics diagnostics checks throughout oncology and different areas – together with neuropsychiatry, radiology and cardiology – to clinicians and hospital techniques.
(Reporting by Angela Christy in Bengaluru; Enhancing by Alan Barona)